Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

MERCK SHARP & DOHME LDA

NIF 500191360
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €18,049,939 158 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €18,049,939 158 contracts
A2 · Late Publication €38,895,866,275 5,116 contracts
Contract published to BASE more than 10 days after the signing date
LOW €38,895,866,275 5,116 contracts
A5 · Threshold Splitting €56,211,335 156 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €56,211,335 156 contracts
A6 · Low Competition €8,314,520 40 contracts
Only one bidder participated in a competitive procedure
MEDIUM €8,314,520 40 contracts
A9 · Price Overrun €225 1 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
HIGH €225 1 contracts
A9 · Abnormal Price Reduction €45,442,571,055 2,432 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €45,442,571,055 2,432 contracts
B5 · Benford's Law Deviation €10,614,025,036 2 contracts
Entity's contract values deviate from the Benford leading-digit distribution (chi-square goodness-of-fit, min 20 contracts). Score: 35 (p<0.05) or 55 (p<0.01).
MEDIUM €10,614,025,036 2 contracts
C3 · Missing Mandatory Fields €27,961,607 86 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €27,961,607 86 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

34
€11,122,355,109
670
€2,512,257,776
91
€1,233,772,691
124
€1,178,089,243
62
€1,162,542,914
95
€1,156,715,443
468
€1,108,080,016
54
€1,050,009,376
80
€1,039,910,866
182
€1,012,755,020
219
€1,009,685,025
249
€1,007,826,847
114
€978,341,343
311
€972,647,453
380
€952,338,699
358
€937,362,050
48
€917,444,812
67
€909,898,846
35
€884,303,408
88
€804,611,977
Page 1 of 4 · 76 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Price Overrun A9 · Abnormal Price Reduction B5 · Benford's Law Deviation C3 · Missing Mandatory Fields

Page 1 of 4 · 156 contracts

VACINA CONTRA O PAPILOMAVIRUS HUMANO 0,5ML SER IM
PT · 13219438 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€143,650 2026-02-06
ERTAPENEM 1G IV INJ AMP - PC.03918.2025
PT · 12227731 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,089 2025-11-07
VACINA CONTRA HEPATITE A 1440 U ELISA/1 ML SUSP INJ FR 1 ML IM (HAVRIX ADULTO) E INFANTIL - 2024/963
PT · 11868524 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€145,142 2025-10-29
ADCM 4354/25 - MEDICAMENTOS DIVERSOS
PT · 5f101ea457b9c2fcddab · Ajuste Direto Regime G...
A2 · Late Publication A5 · Threshold Splitting
€19,800 2025-10-14
ADCM 3772/25 - MEDICAMENTOS DIVERSOS
PT · cff0ae2509e0e83d3aaa · Ajuste Direto Regime G...
A2 · Late Publication A5 · Threshold Splitting
€19,800 2025-08-29
AQUISIÇÃO DE VARIOS MEDICAMENTOS SPMS PARA 2025 - 3 - ULSLO
PT · 12718591 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€148,032 2025-04-09
251000338/13559 - MYCOBACTERIUM BOVIS SOL INJ 81 M
PT · 11321823 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€19,800 2025-04-02
VACINA
PT · 11535911 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€4,752 2025-03-05
Aquisição de IMIPENEM 500 MG + CILASTATINA 500 MG + RELEBACTAM 250 MG PÓ SOL INJ FR IV
PT · 11247205 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A6 · Low Competition
€72,397 2025-02-17
Medicamentos
PT · 11325045 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€74,849 2025-01-08
MEDICAMENTOS
PT · 11130350 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€74,145 2024-12-18
cefTOLOZANO
PT · 11227970 · Ajuste Direto Regime G...
A5 · Threshold Splitting C3 · Missing Mandatory Fields
€4,890 2024-12-18
251000020- Medicamentos Diversos
PT · 11109059 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€142,919 2024-12-11
cefTOLOZANO
PT · 11006555 · Ajuste Direto Regime G...
A2 · Late Publication A5 · Threshold Splitting
€4,890 2024-10-21
MEDICAMENTOS
PT · 10979973 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€71,694 2024-10-09
cefTOLOZANO 1 g + Tazobactam 0.5 g Pó
PT · 11029748 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€4,890 2024-10-08
MEDICAMENTOS
PT · 10897804 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€74,294 2024-08-28
cefTOLOZANO 1 g + Tazobactam 0.5 g Pó conc sol inj Fr IV
PT · 10948890 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€4,890 2024-08-22
Ceftolozano + Tazobactam
PT · 10895899 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€4,890 2024-08-22
C/ BASE NO CPA 2022_40
PT · 10961678 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,758 2024-08-06
Ceftolozano
PT · 10872470 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€4,890 2024-07-31
Ceftolozano 1 g + Tazobactam 0.5 g Pó conc sol inj Fr IV
PT · 10816957 · Ajuste Direto Regime G...
A2 · Late Publication A5 · Threshold Splitting
€4,890 2024-06-21
VÁRIOS MEDICAMENTOS
PT · 10767557 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€19,694 2024-06-05
VÁRIOS MEDICAMENTOS
PT · 10769824 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,694 2024-06-05
J1/1302/2024 - IMIPENEM 500 MG + CILASTINA 500 MG + RELEBACTAM 250 MG PO SOL INJ IV
PT · 10754271 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€72,397 2024-04-16
DMF - MEDICAMENTOS DIVERSOS (SPMS CAPS 2022-055)
PT · 10655869 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€74,067 2024-03-21
MEDICAMENTOS
PT · 10295164 · Ajuste Direto Regime G...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€73,656 2023-10-11
231000521/13559 - VÁRIOS MEDICAMENTOS
PT · 10270589 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€146,285 2023-10-02
C/BASE NO CPA 2021_67
PT · 10178281 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,075 2023-07-10
C/ BASE NO CPA 2021_67
PT · 9998275 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€19,075 2023-05-09
2023004275 - FAR_HOSP_PL - VACINAS HEPATITE
PT · 9977682 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€4,950 2023-05-02
2023003571 - FAR_HOSP_PL - VACINAS HEPATITE A
PT · 10189136 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€4,950 2023-03-28
Aquisição de vacinas do PNV 2023, para 2 meses, ao abrigo dos CPA dos SPMS, com consulta ao Catálogo de Aprovisionamento Público da Saúde (CAPS)
PT · 9895444 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€146,829 2023-03-23
Aquisição de Ceftolozano 1 g + Tazobactam 0.5 g Pó conc sol inj Fr IV
PT · 10409036 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€73,350 2023-03-16
MEDICAMENTOS DIVERSOS
PT · 9947075 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,924 2023-03-15
AE 278/ 2023 - LETERMOVIR 240 MG INJ-
PT · 9706566 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€144,050 2023-01-12
CEFTOLOZANO 1G+ TAZOBACTAM 0.5G AMP
PT · 9861984 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€4,890 2022-10-19
DORAVIRINA 100 MG COMP
PT · 9418253 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€19,758 2022-08-08
Aquisição de Medicamentos do aparelho cardiovascular ao abrigo do CPA 2020/1
PT · 9377167 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€145,166 2022-07-07
PQ/1592/2022 Medicamentos
PT · 9265542 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€4,915 2022-05-17
4180211/2022-DORAVIRINA 100 MG COMP REVES, DOLUTEGRAVIR 50 MG + RILPIVIRINA 25 MG COMP REVES
PT · 9849748 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€4,894 2022-03-25
PA Nº 126/PA/HPSJD/2022 - Aquisição de bens para os Serviços Farmacêuticos do Hospital Prisional em 2022.
PT · 9127499 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€19,348 2022-03-16
Aquisição de SUGAMADEX, IV 100MG/ML; 2ML, SOL INJ ao abrigo do CPA 2020/50 para o HFF para o ano 2021
PT · 9914125 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€74,296 2021-12-02
SUGAMADEX 100MG/ML SOL INJ FRS 2ML IV AMP
PT · 8536287 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€148,592 2021-11-25
MEDICAMENTOS
PT · 8469573 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€72,869 2021-11-24
MEDICAMENTOS
PT · 8466573 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€74,010 2021-11-03
ANTIVIRICOS - RALTEGRAVIR 400 MG COMP 2º SEMESTRE
PT · 8047789 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€74,541 2021-09-22
P259-2021-055 - Aquisição de vacinas para cumprimento do Programa Nacional de Vacinação 2021
PT · 7833055 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€5,221,266 2021-08-19
P259-2021-055 - Aquisição de vacinas para cumprimento do Programa Nacional de Vacinação 2021
PT · 10741331 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€5,221,266 2021-07-14
P259-2021-055 - Aquisição de vacinas para cumprimento do Programa Nacional de Vacinação 2021
PT · 7767624 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€5,221,266 2021-06-24
Next →
Overview
Total Value Won
€45,905,468,352
Contracts Won
7,073
Score 245005 · CRITICAL RISK
NIF
500191360
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

No director data imported yet.

Director and fiscal identity data for Portuguese companies can be found in the Registo Comercial (publicacoes.mj.pt).

Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned